153 related articles for article (PubMed ID: 30402386)
61. Utility of BAP1, p16, and Methylthio-Adenosine Phosphorylase Immunohistochemistry in Cytological and Histological Samples of Pleural Mesotheliomas.
Amacher V; Bode PK; Moch H; Lenggenhager D; Vrugt B
Acta Cytol; 2023; 67(4):444-450. PubMed ID: 36889303
[TBL] [Abstract][Full Text] [Related]
62. Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology.
Girolami I; Lucenteforte E; Eccher A; Marletta S; Brunelli M; Graziano P; Pisapia P; Malapelle U; Troncone G; Scarpa A; Huang T; Pantanowitz L
Cancer Cytopathol; 2022 Feb; 130(2):96-109. PubMed ID: 34478240
[TBL] [Abstract][Full Text] [Related]
63. Fine needle aspiration of follicular variant of papillary thyroid carcinoma presenting with pleural effusion: a case report.
Siddaraju N; Viswanathan VK; Saka VK; Basu D; Shanmugham C
Acta Cytol; 2007; 51(6):911-5. PubMed ID: 18077985
[TBL] [Abstract][Full Text] [Related]
64. Unusual Presentation of Bilateral Chylothorax and Chylous Ascites with Pancreatic Adenocarcinoma: A Case Report.
Fangsaard P; Puriwekin J; Phattraprayoon N; Ungtrakul T
Case Rep Oncol; 2022; 15(2):611-616. PubMed ID: 35949900
[TBL] [Abstract][Full Text] [Related]
65. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B
Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
[TBL] [Abstract][Full Text] [Related]
66. Diagnosis of Mesothelioma Using Flexible Bronchoscopy With Endobronchial Ultrasound-guided Biopsy of Mediastinal Lymph Nodes.
Mukherjee I; Yi E; Utz J
J Bronchology Interv Pulmonol; 2009 Jul; 16(3):207-10. PubMed ID: 23168556
[TBL] [Abstract][Full Text] [Related]
67. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
Chung CT; Santos Gda C; Hwang DM; Ludkovski O; Pintilie M; Squire JA; Tsao MS
J Clin Pathol; 2010 Jul; 63(7):630-4. PubMed ID: 20591913
[TBL] [Abstract][Full Text] [Related]
68. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report.
Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M
Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457
[TBL] [Abstract][Full Text] [Related]
69. The Use of Immunohistochemistry, Fluorescence
Rozitis E; Johnson B; Cheng YY; Lee K
Front Oncol; 2020; 10():1742. PubMed ID: 33014860
[TBL] [Abstract][Full Text] [Related]
70. Stage Ia malignant pleural mesothelioma: clinical course and appropriate diagnostic process.
Maeda R; Isowa N; Onuma H; Miura H; Touge H; Kawasaki Y
Gen Thorac Cardiovasc Surg; 2009 May; 57(5):264-8. PubMed ID: 19440826
[TBL] [Abstract][Full Text] [Related]
71. [A case of malignant pleural mesothelioma with elevation of G-CSF and CYFRA in the serum and pleural fluid].
Inoue C; Kato S; Higuchi K; Inoue H
Nihon Kokyuki Gakkai Zasshi; 2007 Mar; 45(3):243-7. PubMed ID: 17419436
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
[TBL] [Abstract][Full Text] [Related]
73. [A resected case of diffuse malignant pleural mesothelioma diagnosed by thoracoscopic biopsy].
Shibuya K; Yusa T; Iyoda A; Hiroshima K
Nihon Kyobu Geka Gakkai Zasshi; 1997 Sep; 45(9):1581-6. PubMed ID: 9341263
[TBL] [Abstract][Full Text] [Related]
74. A Case of Systemic Lupus Erythematosus with Malignant Pleural Mesothelioma in a 42-year Woman.
Liu Y; Tong J; Ling X; Cao W; Fang L
J Coll Physicians Surg Pak; 2020 Oct; 30(10):1099-1101. PubMed ID: 33143837
[TBL] [Abstract][Full Text] [Related]
75. Hepatic Chylothorax: An Uncommon Pleural Effusion.
Akbar A; Hendrickson T; Vangara A; Marlowe S; Hussain A; Ganti SS
J Investig Med High Impact Case Rep; 2023; 11():23247096221150634. PubMed ID: 36644885
[TBL] [Abstract][Full Text] [Related]
76. Non-asbestos-related malignant pleural mesothelioma.
Kanbay A; Ozer Simsek Z; Tutar N; Yılmaz I; Buyukoglan H; Canoz O; Demir R
Intern Med; 2014; 53(17):1977-9. PubMed ID: 25175133
[TBL] [Abstract][Full Text] [Related]
77. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
Bruno R; Alì G; Fontanini G
J Thorac Dis; 2018 Jan; 10(Suppl 2):S342-S352. PubMed ID: 29507804
[TBL] [Abstract][Full Text] [Related]
78. [Fetal pleural effusion in the uterus and dyspnea after birth].
Lyu M; Liao ZC; Yu XH; Wang MJ; Yue SJ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):892-896. PubMed ID: 32800038
[TBL] [Abstract][Full Text] [Related]
79. Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.
Bakhshayesh Karam M; Karimi S; Mosadegh L; Chaibakhsh S
Iran J Radiol; 2016 Jan; 13(1):e10949. PubMed ID: 27110327
[TBL] [Abstract][Full Text] [Related]
80. The "Brescia panel" (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas.
Bernardi L; Bizzarro T; Pironi F; Szymczuk S; Buda R; Fabbri E; Di Claudio G; Rossi G
Cancer Cytopathol; 2021 Apr; 129(4):275-282. PubMed ID: 33045147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
